Yuki Satoshi

• 2024 - 2027 Effect of tumor microbiome on tumor immune evasion in pancreatic cancer
• 2019 - 2022 Effect of amnion-derived mesenchymal stem cells for the treatment of radiation-induced oral mucositis

• Hiroshi Nakatsumi, Yoshito Komatsu, Kazuaki Harada, Yasuyuki Kawamoto, Satoshi Yuki, Kentaro Sawada, Atsushi Ishiguro, Susumu Sogabe, Takayuki Ando, Yusuke Sasaki, et al. A multicenter, prospective, phase II trial of second-line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti-EGFR antibody: HGCSG1801. International journal of cancer. 2024
• Akira Ueda, Satoshi Yuki, Takayuki Ando, Ayumu Hosokawa, Naokatsu Nakada, Yosuke Kito, Iori Motoo, Ken Ito, Miho Sakumura, Yurika Nakayama, et al. CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer. Cancers. 2024. 16. 5
• Akira Ueda, Satoshi Yuki, Takayuki Ando, Ayumu Hosokawa, Naokatsu Nakada, Yosuke Kito, Iori Motoo, Ken Ito, Miho Sakumura, Yurika Nakayama, et al. CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer. Cancers. 2024. 16. 5
• 田中 佑実, 畑中 佳奈子, 奥村 麻美, 南家 綾江, 結城 敏志, 本間 重紀, 木下 一郎, 松野 吉宏, 畑中 豊. KRAS変異陽性大腸癌に対する治療標的分子としてのCD73/NT5E発現に関する分子病理学的検討. 日本病理学会会誌. 2024. 113. 1. 310-310
• Satoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, Hiroya Taniguchi, Hideaki Bando, Manabu Shiozawa, Tomohiro Nishina, Hisateru Yasui, Akiyoshi Kanazawa, Koji Ando, et al. Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit Study. Clinical colorectal cancer. 2024

ｍore...

• 田中佑実, 畑中佳奈子, 奥村麻美, 南家綾江, 南家綾江, 結城敏志, 本間重紀, 木下一郎, 松野吉宏, 畑中豊, et al. CD73/NT5E expression as a therapeutic target for KRAS-mutated colorectal cancer. 日本病理学会会誌. 2024. 113. 1
• Kentaro Yamazaki, Satoshi Yuki, Hiroya Taniguchi, Hideaki Bando, Yu Sunakawa, Manabu Shiozawa, Hisateru Yasui, Naoki Takahashi, Hironaga Satake, Nobuhisa Matsuhashi, et al. Impact of plasma VEGF-A, VEGF-D and PlGF on the efficacy of 2nd-line chemotherapy combined with biologics in mCRC. ANNALS OF ONCOLOGY. 2022. 33. S479-S479
• Yoshinori Kagawa, Daisuke Kotani, Hideaki Bando, Naoki Takahashi, Tetsuya Hamaguchi, Akiyoshi Kanazawa, Takeshi Kato, Koji Ando, Hironaga Satake, Eiji Shinozaki, et al. Plasma RAS dynamics and anti-EGFR rechallenge efficacy in patients with RAS/BRAF wild-type metastatic colorectal cancer: REMARRY and PURSUIT trials. JOURNAL OF CLINICAL ONCOLOGY. 2022. 40. 16
• Satoshi Yuki, Yu Sunakawa, Kentaro Yamazaki, Hiromichi Shirasu, Hiroya Taniguchi, Toshiki Masuishi, Manabu Shiozawa, Hideaki Bando, Tomohiro Nishina, Hisateru Yasui, et al. Analysis of plasma angiogenesis factors on the efficacy of first-line (1L) chemotherapy (chemo) combined with biologics in RAS wild-type metastatic colorectal cancer (mCRC): Results from GI-SCREEN CRC Ukit study. JOURNAL OF CLINICAL ONCOLOGY. 2022. 40. 16
• 塚田 祐一郎, 坂東 英明, 稲守 宏冶, 冨樫 庸介, 結城 敏志, 小松 嘉人, 本間 重紀, 武冨 紹信, 植村 守, 加藤 健志, et al. 大腸癌周術期治療の臨床開発と将来展望 進行直腸癌に対する化学放射線療法と免疫チェックポイント阻害剤を用いた術前治療. 日本癌治療学会学術集会抄録集. 2021. 59回. SY2-4

ｍore...

• NORTH/HGCSG1003 Stage III結腸癌に対する術後補助化学療法FOLFOXの第II相研究 腫瘍内科医と外科医の比較
  (日本大腸肛門病学会雑誌 2019)
• XELOX+bevacizumab療法が奏効しR0切除が得られたAFP産生大腸癌同時性肝転移の1例
  (日本外科系連合学会誌 2018)
• Imatinib不応・不耐GISTに対するsunitinibの有効性について 遺伝子変異別の検討
  (日本癌治療学会学術集会抄録集 2017)
• HER2陽性胃癌に対するトラスツズマブ/イリノテカン併用療法の第II相試験(HGCSG1201)
  (日本癌治療学会学術集会抄録集 2017)
• 前治療における腫瘍増殖速度がレゴラフェニブとTAS-102の抗腫瘍効果に与える影響
  (日本癌治療学会学術集会抄録集 2017)

ｍore...

• 医学博士 (北海道大学)

The Japan Gastroenterological Endoscopy Society ,  The Japanese Society of Gastroenterology ,  Japanese Association for Cancer Prevention ,  Japanese Association of Supportive Care in Cancer ,  The Japanese Society for Familial Tumors ,  Japanese Gastric Cancer Association ,  Japan Society of Clinical Oncology ,  The Japanese Society of Internal Medicine ,  European Society of Medical Oncology ,  American Society of Clinical Oncology ,  Japanese Society of Medical Oncology